Asia Pacific Point of Care Diagnostics Market Size To Worth USD 20.77 Billion By 2033 | CAGR of 8.37%
Category: HealthcareAsia Pacific Point of Care Diagnostics Market Size To Worth USD 20.77 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Asia Pacific Point of Care Diagnostics Market Size is to Grow from USD 9.30 Billion in 2023 to USD 20.77 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.37% during the projected period.
Get more details on this report -
Browse key industry insights spread across 198 pages with 100 Market data tables and figures & charts from the report on the "Asia Pacific Point of Care Diagnostics market Size, Share, and COVID-19 Impact Analysis, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Fertility/Pregnancy, and Infectious Disease), By End User (Clinics, Hospitals, Home Assisted Living Healthcare Facilities, and Laboratory), By Country (China, Japan, India, South Korea, Australia, Rest of the APAC), and Asia Pacific Point Of Care Diagnostics Market Insights Forecasts to 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/asia-pacific-point-of-care-diagnostics-market
Point-of-care (POC) diagnostics are medical diagnostic tests that are performed at the patient's location or close by rather than in a traditional laboratory. The main advantage of POC diagnostics is their ability to generate results rapidly, and frequently within minutes, enabling medical practitioners to offer recommendations or choose a course of treatment immediately based on test results. The growing prevalence of target disorders such as diabetes, cancer, heart disease, and infectious diseases is expected to propel market expansion. Demand for point-of-care (POC) diagnostics is expected to rise as a result of the high number of medical demands associated with this disease and the resulting rise in patient awareness observed throughout Asia Pacific. However, the growth of the market is constrained by the pricing pressure caused by differences in reimbursements.
The glucose testing segment is anticipated to hold the largest revenue share of the Asia Pacific point of care diagnostics market during the forecast period.
Based on the product, the Asia Pacific point of care diagnostics market is classified into glucose testing, Hb1Ac testing, coagulation, fertility/pregnancy, and infectious disease. Among these, the glucose testing segment is anticipated to hold the largest revenue share of the Asia Pacific point of care diagnostics market during the forecast period. A number of factors, including rapid urbanization, shifting lifestyles, and dietary choices, are contributing to the increase in diabetes incidence in the area. This has led to an increased demand for accurate, user-friendly glucose monitoring equipment.
The clinics segment is anticipated to dominate the Asia Pacific point of care diagnostics market during the forecast period.
Based on the end user, the Asia Pacific point of care diagnostics market is classified into clinics, hospitals, home assisted living healthcare facilities, and laboratories. Among these, the clinics segment is anticipated to dominate the Asia Pacific point of care diagnostics market during the forecast period. Clinics are essential for providing healthcare services, particularly in poor and rural areas. Point-of-care diagnostics allows clinics to diagnose and test patients right away without needing laboratory samples.
Major vendors in the Asia Pacific point of care diagnostics market include Qiagen, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Becton Dickinson (BD), bioMérieux, Abbott, Nova Biomedical, SEKISUI MEDICAL CO., LTD., and Others.
Recent Developments
- In December 2023, Carmot Therapeutics was acquired by F. Hoffmann-La Roche Ltd. Carmot's current R&D portfolio, comprising all assets in the clinical and pre-clinical stages, was made available to Roche as part of this transaction. These resources, which are utilized in the study to treat possible diabetes and obesity, include CT-996, CT-868, and CT-388.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Asia Pacific point of care diagnostics market based on the below-mentioned segments:
Asia Pacific Point of Care Diagnostics Market, By Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility/Pregnancy
- Infectious Disease
Asia Pacific Point of Care Diagnostics Market, By End User
- Clinics
- Hospitals
- Home Assisted Living Healthcare Facilities
- Laboratory
Asia Pacific Point of Care Diagnostics Market, By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of the APAC
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?